Skip to content
AnalystLens

Labcorp Holdings 8-K Report, Regulation FD Disclosure (Apr 9, 2026)

Reports
Regulation FD·Exhibits & Filings
Filing Date
Filed April 9, 2026
Period End
April 8, 2026
Security
LH
In the record · 2016–202610-K1310-Q338-K382

LH filed 13 annual reports (10-K), 33 quarterly reports (10-Q) and 382 current reports (8-K) between 2016 and 2026.

  1. Restructuring8-K · Apr ’17Apr ’17
  2. Leadership change8-K · Jun ’19Jun ’19
  3. Material agreement8-K · May ’21May ’21
  4. Material agreement8-K · Jun ’25Jun ’25

Summary

Summary of the 8-K filed April 9, 2026. Cited figures are marked; the original filing is the authoritative source.

Labcorp Holdings Inc. (NYSE: LH) filed a Current Report on Form 8-K on April 9, 2026, under Item 7.01 (Regulation FD Disclosure) to announce that its Board of Directors has declared a quarterly cash dividend of $0.72a per share of common stock.

The dividend is payable on June 11, 2026, to stockholders of record as of the close of business on May 29, 2026. The filing is a routine capital return announcement with no financial results, guidance, or operational updates included in the 8-K itself. The accompanying press release, furnished as Exhibit 99.1 and incorporated by reference, carries the same dividend details and describes Labcorp as a global laboratory services provider with nearly 71,000 employees serving clients in approximately 100 countries.

For investors, the key takeaways are the dividend amount, the record date, and the payment date. The filing does not disclose any other financial metrics, and the Exhibit 99.1 press release contains no additional financial data beyond the dividend announcement.

Key Highlights

  1. Board declared a quarterly cash dividend of $0.72 per share of common stock
  2. Dividend payable June 11, 2026
  3. Stockholders of record as of close of business May 29, 2026 are entitled to the dividend
  4. Disclosed under Item 7.01 (Regulation FD Disclosure) via 8-K filed April 9, 2026
  5. Press release (Exhibit 99.1) furnished and incorporated by reference, containing the same dividend details
  6. Labcorp describes itself as serving clients in approximately 100 countries, with nearly 71,000 employees
  7. Company states it provided support for 85% of new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests annually

Frequently Asked Questions

  1. How much is the dividend and when will it be paid?

    Labcorp's Board of Directors declared a cash dividend of $0.72 per share of common stock, payable on June 11, 2026.

  2. Who is eligible to receive the dividend?

    Stockholders of record as of the close of business on May 29, 2026 are eligible to receive the dividend.

  3. Does this filing include financial results or guidance?

    No. The 8-K covers only the dividend declaration under Item 7.01, and the furnished press release (Exhibit 99.1) announces the dividend without including financial results or guidance.

  4. What does the filing say about Labcorp's business?

    The press release describes Labcorp as a global leader of laboratory services, with nearly 71,000 employees serving clients in approximately 100 countries, supporting 85% of new drugs and therapeutic products approved by the FDA in 2025, and performing more than 750 million tests annually.